Mechanistic target of rapamycin enhances fibrosis in lung by promoting epithelial mesenchymal transition

M. Saito (Tokyo, Japan), A. Mitani (Tokyo, Japan), T. Ishimori (Tokyo, Japan), H. Isago (Tokyo, Japan), Y. Mikami (Tokyo, Japan), S. Noguchi (Tokyo, Japan), Y. Morishita (Tokyo, Japan), T. Nagase (Tokyo, Japan)

Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Session: Intercellular communication in tissue remodelling of chronic lung diseases
Session type: Oral Presentation
Number: 468
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Saito (Tokyo, Japan), A. Mitani (Tokyo, Japan), T. Ishimori (Tokyo, Japan), H. Isago (Tokyo, Japan), Y. Mikami (Tokyo, Japan), S. Noguchi (Tokyo, Japan), Y. Morishita (Tokyo, Japan), T. Nagase (Tokyo, Japan). Mechanistic target of rapamycin enhances fibrosis in lung by promoting epithelial mesenchymal transition. 468

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

The role of resident lung mesenchymal stromal cells in normal and aberrant lung development
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020




PTEN deficiency in alveolar type 2 cells accelerates cellular senescence, disrupts epithelial–mesenchymal and mitochondrial homeostasis, and induces age-related emphysema
Source: International Congress 2019 – Cellular metabolism and immune senescence in lung pathology
Year: 2019



Synergistic role of HSP90a and HSP90ß to promote myofibroblast persistence in lung fibrosis
Source: Eur Respir J, 51 (2) 1700386; 10.1183/13993003.00386-2017
Year: 2018



Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012



Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018


Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

PP205 – Effect of mTOR inhibition in a 3D in vitro model of alveolar epithelium and epithelial regeneration
Source: ERS Lung Science Conference 2021
Year: 2021

HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Primary human airway epithelial cells inhibit proliferation of lung fibroblasts via transforming growth factor-β
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007


Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Ac-SDKP increases a-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-ß1 and silica
Source: International Congress 2019 – Air pollution and the lungs
Year: 2019

Epithelial fibroblast triggering and interactions in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 123-129
Year: 2008



Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015



Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC)
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012